Using biotechnology to create the next generation of sustainable foods from the roots of mushrooms
Mushlabs uses proprietary fermentation technology to cultivate mycelium into a sustainable, protein-rich meat alternative, aiming to transform plant-based diets.
Projectdetails
Introduction
Mushlabs is a biotech company that produces meat replacement from mushroom roots called mycelium. We have developed our proprietary fermentation technology to create mushroom biomass: a meat replacement ingredient revolutionizing plant-based alternative proteins.
Mission
Our mission is to change the way people eat by producing tastier, healthier, and more sustainable foods.
Cultivation Process
We take pieces of mycelium and cultivate them in a controlled and optimal environment. These serve as the seed for the mushroom biomass we harvest.
Feeding the Mycelium
We feed the mycelium with side streams from the agro and food industries. In large bioreactors, the mushroom mycelial cells ferment the side streams and multiply.
Biological Process
This biological process accumulates biomass rich in protein, dietary fiber, and micronutrients with a savoury flavour, which serves as the main raw ingredient for all of our products.
Product Development
With very few ingredients and little food processing, we create delicious, healthy, and sustainable everyday foods that replace meat.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.426.375 |
Totale projectbegroting | € 3.467.500 |
Tijdlijn
Startdatum | 1-11-2022 |
Einddatum | 31-10-2024 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- MUSHLABS GMBHpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A Revolutionary Tech for Exceptionally Efficient Natural Muscle Tissue Growth in Cultivated Meat ApplicationsProFuse aims to optimize a novel myoblast cell line and media supplement to enhance the scalability and quality of cultivated meat, targeting TRL6 validation with potential clients. | EIC Transition | € 2.432.030 | 2024 | Details |
Technische en Economische haalbaarheid van Mycelium voorkweek in de productie van Mycoproteïnes op reststromen.Het project onderzoekt de haalbaarheid van een voorkweekproces om de fermentatieduur van mycoproteïnes uit reststromen met 30% te verkorten, gericht op de vlees- en visvervangende industrie. | MIT Haalbaarheid | € 20.000 | 2023 | Details |
Insect- and Fungi-based Biodegradation FacilityDit project richt zich op het duurzaam produceren van eiwitten uit insecten en paddenstoelen via een circulaire afvalverwerkingsfaciliteit, met als doel economische waarde en klimaatneutraliteit te realiseren. | MIT Haalbaarheid | € 19.968 | 2022 | Details |
Symbiotische fermentatie met Vitamine B12Nutrilab ontwikkelt een innovatieve symbiotische fermentatie om eiwitten uit vruchten te benutten en vitamine B12 te produceren, gericht op duurzame vleesvervangers die aan consumentenbehoeften voldoen. | MIT Haalbaarheid | € 20.000 | 2021 | Details |
A Revolutionary Tech for Exceptionally Efficient Natural Muscle Tissue Growth in Cultivated Meat Applications
ProFuse aims to optimize a novel myoblast cell line and media supplement to enhance the scalability and quality of cultivated meat, targeting TRL6 validation with potential clients.
Technische en Economische haalbaarheid van Mycelium voorkweek in de productie van Mycoproteïnes op reststromen.
Het project onderzoekt de haalbaarheid van een voorkweekproces om de fermentatieduur van mycoproteïnes uit reststromen met 30% te verkorten, gericht op de vlees- en visvervangende industrie.
Insect- and Fungi-based Biodegradation Facility
Dit project richt zich op het duurzaam produceren van eiwitten uit insecten en paddenstoelen via een circulaire afvalverwerkingsfaciliteit, met als doel economische waarde en klimaatneutraliteit te realiseren.
Symbiotische fermentatie met Vitamine B12
Nutrilab ontwikkelt een innovatieve symbiotische fermentatie om eiwitten uit vruchten te benutten en vitamine B12 te produceren, gericht op duurzame vleesvervangers die aan consumentenbehoeften voldoen.